4,6-dimethylcinnoline | 20873-28-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 4,6-dimethylcinnoline
• 英文别名: 4,6-Dimethyl-cinnolin
• CAS: 20873-28-3
• 化学式: C₁₀H₁₀N₂
• 分子量: 158.203
• InChiKey: SFYXKILVPLPBKP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  25.8
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4,6-dimethylcinnoline 生成 6-Methyl-4-(trichloromethyl)cinnoline
  参考文献：
  名称：

  JOHN, WILLIAM W.;ESTREICHER, HERBERT;SOLOWAY, SAMUEL B.

  摘要：

  DOI：
• 作为产物：
  描述：

  4-methyl-2-(prop-1-en-2-yl)aniline 生成 4,6-dimethylcinnoline
  参考文献：
  名称：

  JOHN, WILLIAM W.;ESTREICHER, HERBERT;SOLOWAY, SAMUEL B.

  摘要：

  DOI：

文献信息

• Flash vacuum pyrolysis of 1-azolyl-1-phenylhydrazono-2-propanones
  作者：Osman M. E. El-Dusouqui、Hicham H. Dib、Nouria A. Al-Awadi、Mervat M. Abdelkhalik、Alya M. Al-Etaibi

  DOI：10.1002/jhet.5570440135

  日期：2007.1

  Flash vacuum pyrolysis (FVP) of 1-(2-arylhydrazono)-1-(1H-1,2,4-triazol-1-yl)acetone 8a-c at 650 °C and 2.67 Pa yielded 5-substituted 1-(1H-indazol-3-yl)ethanone 14a-c and 4,6-disubstituted cinnoline 18a-c. Similarly FVP of 1-(1H-benzo[d]imidazol-1-yl)-1-(2-phenylhydrazono)acetone 9a-c gave 8H-benzo[4′,5′]imidazo[2′,1′:5,1]pyrrolo[2,3-c]cinnoline derivatives 23a-c. A plausible mechanism is suggested

  1-（2-芳基肼基）-1-（1 H -1,2,4-三唑-1-基）丙酮8a-c在650°C和2.67 Pa下的快速真空热解（FVP）得到5-取代的1- （1 H-吲唑-3-基）乙酮14a-c和4，6-二取代的cinnoline 18a-c。类似地，将1-（1 H-苯并[ d ]咪唑-1-基）-1-（2-苯基肼基）丙酮9a-c的FVP得到8 H-苯并[4'，5']咪唑[2'，1' ：5,1] pyrrolo [2,3- c ] cinnoline衍生物23a-c。建议根据反应的动力学和产物来考虑其转化的合理机制。
• Use of certain cinnoline-4-carboxylic acids and congeners thereof for
  申请人：E. I. Du Pont de Nemours and Company

  公开号：US04699651A1

  公开（公告）日：1987-10-13

  The growth of unwanted plants is controlled by certain cinnoline-4-carboxylic acids and congeners thereof.

  不需要翻译，直接给您结果：某些苯并咔啉-4-羧酸及其同系物可控制杂草的生长。
• HETEROCYCLIC COMPOUNDS AND EXPANSION AGENTS FOR HEMATOPOIETIC STEM CELLS
  申请人：Nishino Taito

  公开号：US20120128640A1

  公开（公告）日：2012-05-24

  An expansion agent for hematopoietic stem cells and/or hematopoietic progenitor cells useful for improvement in the efficiency of gene transfer into hematopoietic stem cells for gene therapy useful for treatment of various disorders is provided. An expansion agent for hematopoietic stem cells and/or hematopoietic progenitor cells containing a compound represented by the formula (I) (wherein X, Y, Z, Ar 1 , R 1 , R 2 , R 3 , R 4 , R 5 , R6 and R 7 are as defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof, which can expand hematopoietic stem cells and/or hematopoietic progenitor cells.

  提供一种用于改善基因治疗中将基因转移至造血干细胞以治疗各种疾病的血液干细胞和/或造血祖细胞扩张剂。该扩张剂包含由式(I)表示的化合物（其中X、Y、Z、Ar1、R1、R2、R3、R4、R5、R6和R7如描述中所定义）、该化合物的互变异构体、前药或药学上可接受的盐或其溶剂，能够扩张血液干细胞和/或造血祖细胞。
• Herbicidal cinnoline compounds
  申请人：SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V.

  公开号：EP0212726A2

  公开（公告）日：1987-03-04

  The growth of unwanted plants is controlled by certain optionally substituted cinnoline-4-carboxylic acids and ester, amino, hydroxamic acid and hydrazide derivatives thereof, and salts and N-oxides of such compounds, The invention further includes compositions containing such compounds, the preparation of the compounds and compositions, and certain novel compounds per se.

  某些任选取代的噌啉-4-羧酸及其酯、氨基、羟肟酸和酰肼衍生物，以及这类化合物的盐和 N-氧化物可控制不需要的植物的生长，本发明还包括含有这类化合物的组合物、化合物和组合物的制备方法，以及某些新型化合物本身。
• METHOD FOR PRODUCING MEGAKARYOCYTES AND/OR PLATELETS FROM PLURIPOTENT STEM CELLS
  申请人：Nissan Chemical Industries, Ltd.

  公开号：EP2765187A1

  公开（公告）日：2014-08-13

  An agent for inducing production of megakaryocytes and/or platelets from pluripotent stem cells which is useful for treatment of disease accompanied by a decrease in platelets is provided. A method for producing megakaryocytes and/or platelets, comprising separating hematopoietic progenitor cells from the septal cells in sac-like structures produced by pluripotent stem cells, and culturing the hematopoietic progenitor cells ex vivo in the presence of a compound represented by the formula (I) (wherein R1 to R7, W, X, Y, Z, Ar1 and n are as defined in the description) to differentiate them into megakaryocytes and/or platelets.

  提供了一种诱导多能干细胞产生巨核细胞和/或血小板的制剂，该制剂可用于治疗伴随血小板减少的疾病。 一种生产巨核细胞和/或血小板的方法，包括在多能干细胞产生的囊状结构中将造血祖细胞从隔细胞中分离出来，并在由式（I）代表的化合物（其中R1至R7、W、X、Y、Z、Ar1和n如描述中所定义）存在下体内外培养造血祖细胞，使其分化成巨核细胞和/或血小板。